Adverum Biotechnologies Inc (AVU)

$CVM CEL-SCI Advances Multikine® Immunotherapy for Head and Neck Cancer Through Dual U.S. Registration Study and Saudi Market Entry Strategy https://finance.yahoo.com/healthcare/articles/cel-sci-advances-multikine-immunotherapy-120000636.html

C F O interview

https://youtu.be/Jyryv-152hc

$GNIS Noted about Canouse (or his Brother) . I posted earlier here and always put links for DD (see below) the last filing and for sure the one coming
will show for sure , plus when they update the OTC Markets SS which is over due .
This link on the filing pgs 5-9
https://ww

Frederick Sharp loses his appeal to the Supreme Court of Canada

Canada's high court won't hear appeal of B.C. man facing US$29 million stock fraud penalties

Canada's high court won't hear appeal from B.C. man facing US$29 million stock fraud penalties

htt

Delisting from the Canadian Stock Exchange! Going to be an American ticker! It is now or never to buy!

$CVM - CEL-SCI Advances Multikine® Immunotherapy for Head and Neck Cancer Through Dual U.S. Registration Study and Saudi Market Entry Strategy

https://finance.yahoo.com/healthcare/articles/cel-sci-advances-multikine-immunotherapy-120000636.html

The Psychology of the Big Bet: 10 Reasons Investors Continue to Watch Netlist (NLST)
Gary Wallach
Jul 2






READ IN APP


The stock market is often described as a machine of numbers, balance sheets, and valuation

CPB today is EX for divi, could dip later, but I'm still bullish long term on it

More likely a nasty correction for now. You do know that TRUMPS MAN as Fed Chair will not disclose any information about when and why he manages the Rates. he actually thinks by staying silent it helps making quick decisions. Sounds like TRUMP himself. Wall Street will treat him like the enemy. W

I wish there was a way for them to Stop all buy’s of SEII until they completed their “merger” and current shareholders would be accommodated for their shares.

Great new article by Feuerstein:

>>Biotech is no longer in a “dark place,” as I wrote in February 2025. (That’s still one of my favorite newsletter headlines, by the way.) The rally that began in April 2025 has not stopped, and if anything, has accelerated.

What’s fueli

I would hope they would dilute before this ever got to $100- and then RS it again. I think .12-.19 is really the sweet spot they should keep this garbage in. Regardless, as a shareholder, I always vote in favor of another RS.

SDEV........WHLR.......SURG........YRD......CWD.....................https://stockcharts.com/sc3/ui/?s=CWD&p=d&yr=0&mn=2&dy=12&id=p84071410134

guess now its a wait and see------have NO idea what burtons back story is------but even a "normal" ------"hey its been 2 years , ill just do a nominal 10% holdings reduction"------will ABSOLUTELY evaporate this thing.

Dat’s what I’m tawken bout Willis.

What does "highlights" between 9 and 12 g/ton mean?

Are those the highest results? The average of the whole deposit? Are there established reserves? Resources? Tonnage of mineralized rock? Ounces contained? Cost per oz?

AABB counts on their investors being comple

Kenny just trying to make another nickel

Really BAD NEWS :
https://cleantechnica.com/2026/07/01/hydrogen-demand-shrinks-counted-properly/

Perhaps you should start a go fund me for his defense

Over a million shares accumulated in the last three days! This stock is going to the American stock exchange. There will never be a better buying opportunity than now!

i would like to buy this too,how do you buy this when its in EM.

$JMKE: Jersey Mikes Sandwiches are coming !!!!!!!!!

You know them ......... you love them.


Get your sandwiches on !!!!!!

https://x.com/jerseymikes/status/2066564248558280944?s=20

GO $JMKE

Usually slow before 3-day weekends but it is usually a good time to add a few as well.... $AABB

Because people still mad no numbers are being mentioned

The European Mkt. for Lisdex. is huge
Lisdexamfetamine is widely prescribed across the European ADHD treatment market. It is primarily known by the brand names Elvanse or Tyvense. The market is rapidly expanding, with lisdexamfetamine acting as the second most commonly prescribed ADHD medicin